These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 17204713)
1. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. Turkheimer FE; Edison P; Pavese N; Roncaroli F; Anderson AN; Hammers A; Gerhard A; Hinz R; Tai YF; Brooks DJ J Nucl Med; 2007 Jan; 48(1):158-67. PubMed ID: 17204713 [TBL] [Abstract][Full Text] [Related]
2. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195. Anderson AN; Pavese N; Edison P; Tai YF; Hammers A; Gerhard A; Brooks DJ; Turkheimer FE Neuroimage; 2007 May; 36(1):28-37. PubMed ID: 17398120 [TBL] [Abstract][Full Text] [Related]
3. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. Tomasi G; Edison P; Bertoldo A; Roncaroli F; Singh P; Gerhard A; Cobelli C; Brooks DJ; Turkheimer FE J Nucl Med; 2008 Aug; 49(8):1249-56. PubMed ID: 18632810 [TBL] [Abstract][Full Text] [Related]
4. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment. Kropholler MA; Boellaard R; van Berckel BN; Schuitemaker A; Kloet RW; Lubberink MJ; Jonker C; Scheltens P; Lammertsma AA J Cereb Blood Flow Metab; 2007 Dec; 27(12):1965-74. PubMed ID: 17406654 [TBL] [Abstract][Full Text] [Related]
6. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology. Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290 [TBL] [Abstract][Full Text] [Related]
12. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? Bartels AL; Willemsen AT; Doorduin J; de Vries EF; Dierckx RA; Leenders KL Parkinsonism Relat Disord; 2010 Jan; 16(1):57-9. PubMed ID: 19487152 [TBL] [Abstract][Full Text] [Related]
13. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP. Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184 [TBL] [Abstract][Full Text] [Related]
14. [¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches. Su Z; Herholz K; Gerhard A; Roncaroli F; Du Plessis D; Jackson A; Turkheimer F; Hinz R Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1406-19. PubMed ID: 23715902 [TBL] [Abstract][Full Text] [Related]
15. Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195. Tomasi G; Bertoldo A; Cobelli C; Pavese N; Tai YF; Hammers A; Turkheimer FE Neuroimage; 2011 Apr; 55(3):942-53. PubMed ID: 21195193 [TBL] [Abstract][Full Text] [Related]
16. Validation of an automatic reference region extraction for the quantification of [ García-Lorenzo D; Lavisse S; Leroy C; Wimberley C; Bodini B; Remy P; Veronese M; Turkheimer F; Stankoff B; Bottlaender M J Cereb Blood Flow Metab; 2018 Feb; 38(2):333-346. PubMed ID: 28178885 [TBL] [Abstract][Full Text] [Related]